These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27654253)

  • 21. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
    Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation of neutrophil-to-lymphocyte ratio with the presence and complexity of coronary artery disease: an observational study.
    Sönmez O; Ertaş G; Bacaksız A; Tasal A; Erdoğan E; Asoğlu E; Uyarel H; Göktekin O
    Anadolu Kardiyol Derg; 2013 Nov; 13(7):662-7. PubMed ID: 23912788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-density lipoprotein cholesterol, C-reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiography.
    Alber HF; Wanitschek MM; de Waha S; Ladurner A; Suessenbacher A; Dörler J; Dichtl W; Frick M; Ulmer H; Pachinger O; Weidinger F
    Eur J Clin Invest; 2008 Jun; 38(6):372-80. PubMed ID: 18489399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-sensitivity C-reactive Protein, Lipoprotein(a) and Homocysteine are Risk Factors for Coronary Artery Disease in Japanese Patients with Peripheral Arterial Disease.
    Kumakura H; Fujita K; Kanai H; Araki Y; Hojo Y; Kasama S; Iwasaki T; Ichikawa S; Nakashima K; Minami K
    J Atheroscler Thromb; 2015; 22(4):344-54. PubMed ID: 25296963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of plasma small dense LDL cholesterol with PCSK9 levels in patients with angiographically proven coronary artery disease.
    Zhang Y; Xu RX; Li S; Zhu CG; Guo YL; Sun J; Li JJ
    Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):426-33. PubMed ID: 25770756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
    Koenig W
    Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma pyridoxal 5'-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease.
    Cheng CH; Lin PT; Liaw YP; Ho CC; Tsai TP; Chou MC; Huang YC
    Nutrition; 2008 Mar; 24(3):239-44. PubMed ID: 18312786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma fibronectin level and its association with coronary artery disease and carotid intima-media thickness.
    Orem C; Durmuş I; Kilinç K; Baykan M; Gökçe M; Orem A; Topbaş M
    Coron Artery Dis; 2003 May; 14(3):219-24. PubMed ID: 12702925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of plasma apolipoprotein CIII, high sensitivity C-reactive protein and tumor necrosis factor-α contributes to the clinical features of coronary heart disease in Li and Han ethnic groups in China.
    Chen L; Sun M; Liu H; Ma L; Wang T; Li P; Lin M; Lin H; Chang P; Liu Y
    Lipids Health Dis; 2018 Jul; 17(1):176. PubMed ID: 30053815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated plasma lipoprotein-associated phospholipase A₂ activity is associated with plaque rupture in patients with coronary artery disease.
    Liu CF; Qin L; Ren JY; Chen H; Wang WM; Liu J; Song JX; Li LJ
    Chin Med J (Engl); 2011 Aug; 124(16):2469-73. PubMed ID: 21933589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between traditional cholesterol parameters, lipoprotein particle concentration, novel biomarkers and carotid plaques in retired National Football League players.
    Virani SS; Pompeii L; Lincoln AE; Dunn RE; Tucker AM; Nambi V; Nasir K; Vogel RA; Boone JL; Roberts AJ; Ballantyne CM
    Atherosclerosis; 2012 Jun; 222(2):551-6. PubMed ID: 22525822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes exacerbates angiographic coronary lesion progression in subjects with metabolic syndrome independent of CRP levels.
    Liang KW; Lee WJ; Lee WL; Chen YT; Ting CT; Sheu WH
    Clin Chim Acta; 2008 Feb; 388(1-2):41-5. PubMed ID: 17967444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study).
    Pan HC; Sheu WH; Lee WJ; Lee WL; Liao YC; Wang KY; Lee IT; Wang JS; Liang KW
    Clin Chim Acta; 2015 May; 445():93-100. PubMed ID: 25818243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of fibroblast growth factor 23 and fetuin--A to coronary atherosclerosis.
    Akin F; Celik O; Altun I; Ayca B; Diker VO; Satılmıs S; Sahin C
    J Diabetes Complications; 2015; 29(4):550-5. PubMed ID: 25772252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.
    Koc M; Karaarslan O; Abali G; Batur MK
    Tex Heart Inst J; 2010; 37(1):42-8. PubMed ID: 20200626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating cathepsin K as a potential novel biomarker of coronary artery disease.
    Cheng XW; Kikuchi R; Ishii H; Yoshikawa D; Hu L; Takahashi R; Shibata R; Ikeda N; Kuzuya M; Okumura K; Murohara T
    Atherosclerosis; 2013 May; 228(1):211-6. PubMed ID: 23369704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between Syntax Score and prognostic localization of coronary artery lesions with conventional risk factors, plasma profile markers, and carotid atherosclerosis (CAPP Study 2).
    Cappelletti A; Astore D; Godino C; Bellini B; Magni V; Mazzavillani M; Pagnesi M; Agricola E; Chiesa R; Colombo A; Margonato A
    Int J Cardiol; 2018 Apr; 257():306-311. PubMed ID: 29506713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strong Association between Plasma Dipeptidyl Peptidase-4 Activity and Impaired Cognitive Function in Elderly Population with Normal Glucose Tolerance.
    Chen B; Zheng T; Qin L; Hu X; Zhang X; Liu Y; Liu H; Qin S; Li G; Li Q
    Front Aging Neurosci; 2017; 9():247. PubMed ID: 28798686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.